vs
FiscalNote Holdings, Inc.（NOTE）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是FiscalNote Holdings, Inc.的1.6倍（$35.5M vs $22.2M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -24.7%），FiscalNote Holdings, Inc.自由现金流更多（$-1.9M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -16.8%）
FiscalNote Holdings, Inc.（常称FiscalNote）是一家上市的软件数据与传媒企业，总部位于美国华盛顿特区，2013年由三位创始人创立。核心业务为通过政府关系管理服务FiscalNote GRM提供软件工具、平台、数据服务与资讯，同时依托人工智能平台分析美国待审议法案相关内容。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NOTE vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.2M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -83.7% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | -24.7% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $-2.81 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $22.2M | $35.5M | ||
| Q3 25 | $22.4M | $5.2M | ||
| Q2 25 | $23.3M | $19.2M | ||
| Q1 25 | $27.5M | $14.7M | ||
| Q4 24 | $29.5M | $4.5M | ||
| Q3 24 | $29.4M | $26.1M | ||
| Q2 24 | $29.2M | $14.4M | ||
| Q1 24 | $32.1M | $13.8M |
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-24.9M | $-162.3M | ||
| Q2 25 | $-13.3M | $-171.9M | ||
| Q1 25 | $-4.3M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $-14.9M | $-95.8M | ||
| Q2 24 | $-12.8M | $-97.5M | ||
| Q1 24 | $50.6M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -83.7% | -304.8% | ||
| Q3 25 | -43.4% | -3327.6% | ||
| Q2 25 | -31.9% | -916.8% | ||
| Q1 25 | -50.0% | -1297.9% | ||
| Q4 24 | -19.4% | -4042.4% | ||
| Q3 24 | -23.1% | -377.1% | ||
| Q2 24 | -27.2% | -697.4% | ||
| Q1 24 | -35.6% | -698.4% |
| Q4 25 | — | -304.2% | ||
| Q3 25 | -110.8% | -3135.3% | ||
| Q2 25 | -57.0% | -894.2% | ||
| Q1 25 | -15.4% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | -50.7% | -367.5% | ||
| Q2 24 | -43.6% | -676.6% | ||
| Q1 24 | 157.6% | -662.4% |
| Q4 25 | $-2.81 | $-0.17 | ||
| Q3 25 | $-1.73 | $-0.36 | ||
| Q2 25 | $-0.08 | $-0.41 | ||
| Q1 25 | $-0.03 | $-0.50 | ||
| Q4 24 | $1.88 | $-0.56 | ||
| Q3 24 | $-1.33 | $-0.34 | ||
| Q2 24 | $-0.09 | $-0.40 | ||
| Q1 24 | $0.37 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.3M | $743.3M |
| 总债务越低越好 | $128.4M | $9.6M |
| 股东权益账面价值 | $62.0M | $1.1B |
| 总资产 | $255.1M | $1.5B |
| 负债/权益比越低杠杆越低 | 2.07× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $26.3M | $743.3M | ||
| Q3 25 | $31.2M | $659.8M | ||
| Q2 25 | $38.5M | $525.1M | ||
| Q1 25 | $46.3M | $500.5M | ||
| Q4 24 | $34.6M | $594.4M | ||
| Q3 24 | $32.7M | $427.6M | ||
| Q2 24 | $37.7M | $474.3M | ||
| Q1 24 | $43.6M | $296.3M |
| Q4 25 | $128.4M | $9.6M | ||
| Q3 25 | $131.5M | $11.9M | ||
| Q2 25 | $116.7M | $14.2M | ||
| Q1 25 | $118.0M | $16.4M | ||
| Q4 24 | $147.1M | $19.0M | ||
| Q3 24 | $152.2M | $20.5M | ||
| Q2 24 | $145.9M | $22.9M | ||
| Q1 24 | $153.0M | — |
| Q4 25 | $62.0M | $1.1B | ||
| Q3 25 | $75.5M | $1.0B | ||
| Q2 25 | $95.1M | $919.1M | ||
| Q1 25 | $98.7M | $933.9M | ||
| Q4 24 | $97.8M | $1.0B | ||
| Q3 24 | $98.5M | $524.6M | ||
| Q2 24 | $106.9M | $584.4M | ||
| Q1 24 | $106.1M | $401.2M |
| Q4 25 | $255.1M | $1.5B | ||
| Q3 25 | $273.9M | $1.4B | ||
| Q2 25 | $288.3M | $1.3B | ||
| Q1 25 | $299.7M | $1.3B | ||
| Q4 24 | $326.2M | $1.4B | ||
| Q3 24 | $337.9M | $726.5M | ||
| Q2 24 | $346.3M | $775.9M | ||
| Q1 24 | $357.8M | $557.8M |
| Q4 25 | 2.07× | 0.01× | ||
| Q3 25 | 1.74× | 0.01× | ||
| Q2 25 | 1.23× | 0.02× | ||
| Q1 25 | 1.20× | 0.02× | ||
| Q4 24 | 1.50× | 0.02× | ||
| Q3 24 | 1.54× | 0.04× | ||
| Q2 24 | 1.36× | 0.04× | ||
| Q1 24 | 1.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-279.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.9M | $-47.3M |
| 自由现金流率自由现金流/营收 | -8.7% | -133.1% |
| 资本支出强度资本支出/营收 | 7.4% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-18.6M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-279.0K | $-46.1M | ||
| Q3 25 | $-8.3M | $-117.4M | ||
| Q2 25 | $-6.2M | $-76.4M | ||
| Q1 25 | $3.3M | $-132.0M | ||
| Q4 24 | $-1.3M | $-115.4M | ||
| Q3 24 | $-3.0M | $-59.2M | ||
| Q2 24 | $-3.7M | $-82.2M | ||
| Q1 24 | $2.7M | $-102.3M |
| Q4 25 | $-1.9M | $-47.3M | ||
| Q3 25 | $-10.4M | $-117.6M | ||
| Q2 25 | $-7.7M | $-79.6M | ||
| Q1 25 | $1.3M | $-133.8M | ||
| Q4 24 | $-3.4M | $-116.7M | ||
| Q3 24 | $-5.4M | $-63.8M | ||
| Q2 24 | $-6.5M | $-83.4M | ||
| Q1 24 | $1.0M | $-109.0M |
| Q4 25 | -8.7% | -133.1% | ||
| Q3 25 | -46.2% | -2272.5% | ||
| Q2 25 | -33.0% | -413.9% | ||
| Q1 25 | 4.7% | -907.4% | ||
| Q4 24 | -11.4% | -2567.7% | ||
| Q3 24 | -18.4% | -244.6% | ||
| Q2 24 | -22.1% | -578.5% | ||
| Q1 24 | 3.3% | -789.9% |
| Q4 25 | 7.4% | 3.5% | ||
| Q3 25 | 9.3% | 4.7% | ||
| Q2 25 | 6.4% | 16.4% | ||
| Q1 25 | 7.2% | 12.4% | ||
| Q4 24 | 6.8% | 28.6% | ||
| Q3 24 | 8.3% | 17.5% | ||
| Q2 24 | 9.4% | 8.2% | ||
| Q1 24 | 5.3% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NOTE
| Subscription | $21.2M | 95% |
| Advisory Advertising And Other | $1.0M | 5% |
RXRX
暂无分部数据
